Christina Curtis, PhD, MSc is a Professor of Medicine, Genetics and Biomedical Data Science and an Endowed Scholar at Stanford University where she leads the Cancer Computational and Systems Biology group. Dr. Curtis also serves as the Director of Artificial Intelligence and Cancer Genomics, Director of Breast Cancer Translational Research and Co-Director of the Molecular Tumor Board at the Stanford Cancer Institute. Dr. Curtis’s laboratory leverages computational modeling, high-throughput molecular profiling and experimentation to develop new ways to prevent, diagnose and treat cancer. Her research has helped to redefine the molecular map of breast cancer and led to new paradigms in understanding how human tumors evolve and metastasize. Dr. Curtis is the recipient of numerous awards, including those from the V Foundation for Cancer Research, STOP Cancer and the American Association for Cancer Research (AACR). She received the National Institutes of Health Director's Pioneer Award in 2018, the Stanford Prize in Population Genetics and Society (2020) and was named an In vivo Rising Leader in the Life Sciences (2021) and the Julius B. Kahn Visiting Professor in the Dept of Pharmacology, at Northwestern University (2020). In 2022 she received the AACR Award for Outstanding Achievement in Basic Science. Dr. Curtis is also Kavli Fellow of the National Academy of Sciences, a Susan G. Komen Scholar and a Chan Zuckerberg Biohub Investigator. Dr. Curtis serves as a scientific advisor to multiple academic institutes and biotech as is a member of the AACR Board of Directors. She also serves on the editorial board of journals spanning computational biology to precision oncology.